Premium
Hepatic transit time analysis using contrast enhanced MRI with Gd‐BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers
Author(s) -
Hohmann Joachim,
Newerla Caroline,
Müller Anja,
Reinicke Christine,
Skrok Jan,
Frericks Bernd B.,
Albrecht Thomas
Publication year - 2012
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.23772
Subject(s) - medicine , colorectal cancer , radiology , hepatocellular carcinoma , bolus (digestion) , nuclear medicine , cancer
Purpose: To find out if the hepatic transit time (HTT) shortening, which was already proven in patients with liver metastases by other modalities, can also be detected with MRI. Materials and Methods: The Patient group consisted of 20 subjects with liver metastases from colorectal cancer and the control group of 21 healthy subjects. Baseline and post contrast images were acquired before and after administration of Gd‐BOPTA, using a T1‐weighted bolus test sequence. Arrival times (AT) of the contrast agent for the aorta, the hepatic artery, the portal vein and one hepatic vein were determined. Based on arrival time measurements HTT were calculated. Results: All analyses showed significantly shorter HTT in patients with metastases compared with healthy volunteers ( P < 0.05). There were no false positives using a threshold of 10.4 s for arterial to venous HTT. For aortal to venous and portal to venous HTT a threshold of 12.5 s and 4 s was calculated, respectively. No significant correlation between HTT and involved liver segments, overall volume of metastases or subject age was found. Conclusion: We conclude that HTT measurements using contrast enhanced MRI with Gd‐BOPTA can detect hemodynamic changes due to metastatic liver disease from colorectal cancer. J. Magn. Reson. Imaging 2012; 36:1389–1394. © 2012 Wiley Periodicals, Inc.